Stay updated on Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.

Latest updates to the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNo changes are listed for this page in the provided data.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4. This indicates a new release or patch level was applied.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new publication citation was added to the Publications section, referencing a 2026 Nat Commun article on spatial predictors of response to chemo-immunotherapy in MSS metastatic colorectal cancer. This update broadens the scholarly context available for the MAYA study.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page’s displayed software revision/version changed from v3.5.2 to v3.5.3, reflecting an update to the site template or backend release rather than the underlying study details.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in MGMT-Silenced mCRC Clinical Trial page.